Future-Proofing Gene Therapy Assays: Validation Strategies For Long-Term Success

Industry experts from Precision for Medicine offer invaluable insights into the development of gene therapy immunogenicity assays in this recent presentation. The presenters focused on ensuring regulatory compliance throughout various trial stages, minimizing rework, and selecting the most appropriate assay approach. Viewers will also review the best practices for assay validation, and delve into the key considerations for selecting and validating immunogenicity assays. Whether you are engaged in early assay development or optimizing assays for later-phase trials, this session provides the insights needed to ensure your assays are validated to meet applicable regulatory standards, are fit for use globally, and are robust, compliant, and scalable.